tert-Butyl 3-chloro-3-methylazetidine-1-carboxylate

Catalog No.: 
ACPCRN106
CAS No.: 
1315192-61-0
Molecular Formula: 
C9H16ClNO2
Molecular Weight: 
205.68
tert-Butyl 3-chloro-3-methylazetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$491.00In stockInquiry
250mg95%$784.00In stockInquiry
500mg95%$1307.00In stockInquiry
1g95%$1959.00In stockInquiry
5g95%$5876.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-chloro-3-methylazetidine-1-carboxylate
IUPAC Nametert-butyl 3-chloro-3-methylazetidine-1-carboxylate
MDL No.0
Molecular FormulaC9H16ClNO2
Molecular Weight205.68
SMILESO=C(N1CC(C)(Cl)C1)OC(C)(C)C
InChI KeyPUVGKPGCBHOJPD-UHFFFAOYSA-N
Synonymtert-butyl 3-chloro-3-methyl-azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-chloro-3-methyl-, 1,1-dimethylethyl ester;1-Boc-3-chloro-3-methylazetidine
CAS No.1315192-61-0

Synthetic Route by SureRoute

1. ACPCRN106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRCMQ360 route compound structure diagram
    ACRCMQ36024083-69-0In Stock
  4. Then
  5. ACPCRN106 route product structure diagram
    ACPCRN1061315192-61-0In Stock
Inquiry

2. ACPCRN106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCRN106 route product structure diagram
    ACPCRN1061315192-61-0In Stock
Inquiry

3. ACPCRN106 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPCRN106 route product structure diagram
    ACPCRN1061315192-61-0In Stock
Inquiry

Comments (0)